28036 Phase 2 randomized, placebo-controlled, dose-ranging study to evaluate the safety and efficacy of onabotulinumtoxina for the treatment of platysma prominence
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI